March 1 (UPI) — If patients with stage III colon cancer regularly eat nuts, they have a lower of recurrence and death, according a study.
A study led by researchers with the Yale Cancer Center in New Haven, Conn., published Wednesday, in the Journal of Clinical Oncology, is said to be the first to spotlight the effects of nut intake on colon cancer.
Previously, nut intake has been associated with a lower risk of type 2 diabetes, metabolic syndrome and insulin resistance — conditions often linked to colon cancer.
“These findings are in keeping with several other observational studies that indicate that a slew of healthy behaviors, including increased physical activity, keeping a healthy weight, and lower intake of sugar and sweetened beverages, improve colon cancer outcomes,” Dr.
In addition, disease-free survival increased by 46 percent among the subgroup of nut consumers who ate tree nuts rather than peanuts.